ProCE Banner Activity

Rationale for Immune Checkpoint Inhibitors and Optimizing Treatments for Recurrent or Metastatic HNSCC

Slideset Download
Conference Coverage
Download these slides from a CCO symposium in Austin discussing the rationale for checkpoint inhibition in advanced HNSCC, practical guidance on clinical use, and promising near-future immunotherapies for HNSCC.

Released: May 01, 2019

Expiration: April 29, 2020

No longer available for credit.

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Merck Oncology